117 related articles for article (PubMed ID: 29426355)
1. Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
Corradini S; Pazos M; Schönecker S; Reitz D; Niyazi M; Ganswindt U; Schrodi S; Braun M; Pölcher M; Mahner S; Harbeck N; Engel J; Belka C
Radiat Oncol; 2018 Feb; 13(1):25. PubMed ID: 29426355
[TBL] [Abstract][Full Text] [Related]
2. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
Alaeikhanehshir S; Schmitz RSJM; van den Belt-Dusebout AW; van Duijnhoven FH; Verschuur E; van Seijen M; Schaapveld M; Lips EH; Wesseling J;
Breast Cancer Res Treat; 2024 Feb; 204(1):61-68. PubMed ID: 37964135
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.
Dick AW; Sorbero MS; Ahrendt GM; Hayman JA; Gold HT; Schiffhauer L; Stark A; Griggs JJ
J Natl Cancer Inst; 2011 Jan; 103(2):92-104. PubMed ID: 21200025
[TBL] [Abstract][Full Text] [Related]
4. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.
Greenberg CC; Lipsitz SR; Hughes ME; Edge SB; Theriault R; Wilson JL; Carter WB; Blayney DW; Niland J; Weeks JC
Ann Surg; 2011 Aug; 254(2):339-45. PubMed ID: 21725233
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy for ductal carcinoma in situ: a decision analysis.
Punglia RS; Burstein HJ; Weeks JC
Cancer; 2012 Feb; 118(3):603-11. PubMed ID: 21720992
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.
Stuart KE; Houssami N; Taylor R; Hayen A; Boyages J
BMC Cancer; 2015 Nov; 15():890. PubMed ID: 26555555
[TBL] [Abstract][Full Text] [Related]
7. Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?
Livingston-Rosanoff D; Trentham-Dietz A; Hampton JM; Newcomb PA; Wilke LG
Breast Cancer Res Treat; 2021 Sep; 189(2):463-470. PubMed ID: 34129117
[TBL] [Abstract][Full Text] [Related]
8. A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma
Mittal K; Toss MS; Wei G; Kaur J; Choi DH; Melton BD; Osan RM; Miligy IM; Green AR; Janssen EAM; Søiland H; Gogineni K; Manne U; Rida P; Rakha EA; Aneja R
Clin Cancer Res; 2020 Jun; 26(12):2898-2907. PubMed ID: 31937618
[TBL] [Abstract][Full Text] [Related]
9. Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
Rakovitch E; Gray R; Baehner FL; Sutradhar R; Crager M; Gu S; Nofech-Mozes S; Badve SS; Hanna W; Hughes LL; Wood WC; Davidson NE; Paszat L; Shak S; Sparano JA; Solin LJ
Breast Cancer Res Treat; 2018 Jun; 169(2):359-369. PubMed ID: 29388015
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective.
Bijker N; van Tienhoven G
J Natl Cancer Inst Monogr; 2010; 2010(41):178-80. PubMed ID: 20956825
[TBL] [Abstract][Full Text] [Related]
11. Nonclinical factors associated with the treatment of older women with newly diagnosed low-grade ductal carcinoma in situ.
DeLeire T; Mitchell JM; De La Cruz L; Isaacs C
Cancer; 2024 Apr; 130(7):1041-1051. PubMed ID: 37987170
[TBL] [Abstract][Full Text] [Related]
12. Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study.
de Sousa CFPM; Pereira AAL; Arruda GV; Gouveia AG; Hanna SA; Cruz MRS; Dos Anjos CH; Bevilacqua JLB; Alcantara Filho P; de Moraes FY; Marta GN
Clin Breast Cancer; 2023 Dec; 23(8):e499-e506. PubMed ID: 37758557
[TBL] [Abstract][Full Text] [Related]
13. The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.
Marinovich ML; Azizi L; Macaskill P; Irwig L; Morrow M; Solin LJ; Houssami N
Ann Surg Oncol; 2016 Nov; 23(12):3811-3821. PubMed ID: 27527715
[TBL] [Abstract][Full Text] [Related]
14. Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ.
Shumway DA; McLeod CM; Morrow M; Li Y; Kurian AW; Sabolch A; Hamilton AS; Ward KC; Katz SJ; Hawley ST; Jagsi R
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1237-1245. PubMed ID: 29439886
[TBL] [Abstract][Full Text] [Related]
15. Treatments and Prognosis of the Breast Ductal Carcinoma In Situ.
Wang Y; Peng D; Zhou X; Hu W; Li F
Clin Breast Cancer; 2024 Feb; 24(2):122-130.e2. PubMed ID: 38016910
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai'i.
Taparra K; Fukui J; Killeen J; Sumida K; Loo LWM; Hernandez BY
JAMA Netw Open; 2021 Oct; 4(10):e2128977. PubMed ID: 34668945
[TBL] [Abstract][Full Text] [Related]
17. Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ.
Tsai CJ; Huang HY; Chen FM; Yang YH; Chen LC; Hsieh KP
PLoS One; 2022; 17(1):e0262934. PubMed ID: 35089956
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study.
Mann GB; Skandarajah AR; Zdenkowski N; Hughes J; Park A; Petrie D; Saxby K; Grimmond SM; Murugasu A; Spillane AJ; Chua BH; Badger H; Braggett H; Gebski V; Mou A; Collins JP; Rose AK
Lancet; 2024 Jan; 403(10423):261-270. PubMed ID: 38065194
[TBL] [Abstract][Full Text] [Related]
19. Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ.
Byng D; Thomas SM; Rushing CN; Lynch T; McCarthy A; Francescatti AB; Frank ES; Partridge AH; Thompson AM; Retèl VP; van Harten WH; Grimm LJ; Hyslop T; Hwang ES; Ryser MD
Radiology; 2023 Apr; 307(1):e221210. PubMed ID: 36625746
[TBL] [Abstract][Full Text] [Related]
20. Omission of Radiotherapy for Women With Low-Risk Invasive Cancers That Have a Ductal Carcinoma In Situ Component.
Sorscher S
J Clin Oncol; 2024 Jun; 42(16):1998. PubMed ID: 38489565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
